Physiologically based pharmacokinetics of zearalenone

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 72, Issue 21-22, 2009, Pages 1395-1405

  Shin, Beom Soo ^a   Hong, Seok Hyun ^b   Bulitta, Jürgen B ^c   Lee, Jong Bong ^b   Hwang, Sang Wook ^b   Kim, Hyoung Jun ^b   Yang, Seung Du ^a   Yoon, Hae Seong ^d   Kim, Do Jung ^d   Lee, Byung Mu ^b   Yoo, Sun Dong ^b  

^a Catholic University of Daegu   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c UNIVERSITY AT BUFFALO   (United States)

^d National Institute of Toxicological Research   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ZEARALENONE;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY; ARTICLE; BILIARY EXCRETION; BIOAVAILABILITY; BRAIN; CLEARANCE; CONTROLLED STUDY; ENTEROHEPATIC CIRCULATION; EXPERIMENTAL MODEL; GLUCURONIDATION; HEART; KIDNEY; LIVER; LUNG; MALE; MAXIMUM PLASMA CONCENTRATION; MUSCLE; NONHUMAN; PRIORITY JOURNAL; RAT; SMALL INTESTINE; SPLEEN; STEADY STATE; STOMACH; TESTIS; TISSUE DISTRIBUTION; VEIN; ANIMAL; BLOOD; CHEMISTRY; HEART MUSCLE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; ORAL DRUG ADMINISTRATION; SKELETAL MUSCLE; SPRAGUE DAWLEY RAT;

RATTUS;

ADIPOSE TISSUE; ADMINISTRATION, ORAL; ANIMALS; BRAIN; HUMANS; INJECTIONS, INTRAVENOUS; KIDNEY; LUNG; MALE; MUSCLE, SKELETAL; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; TESTIS; TISSUE DISTRIBUTION; ZEARALENONE;

EID: 75749129927     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287390903212741     Document Type: Article

References (27)

1. Baldwin, R. S., Williams, R. D., and Terry, M. K. 1983. Zeranol: A review of the metabolism, toxicology, and analytical methods for detection of tissue residues. Regul. Toxicol. Pharmacol. 3: 9-25.
2. Bennett, J. W., and Klich M. 2003. Mycotoxins. Clin. Microbiol. Rev. 16: 497-516.
3. Bernareggi, A., and Rowland, M. 1991. Physiologic modeling of cyclosporin kinetics in rat and man. J. Pharmacokinet. Biopharm. 19: 21-50.
4. Biehl, M. L., Prelusky, D. B., Koritz, G. D., Hartin, K. E., Buck, W. B., and Trenholm, H. L. 1993. Biliary excretion and enterohepatic cycling of zearalenone in immature pigs. Toxicol. Appl. Pharmacol. 121: 152-159.
5. Boyd, P. A., and Wittliff, J. L. 1978. Mechanism of Fusarium mycotoxin action in mammary gland. J. Toxicol. Environ. Health 4: 1-8.
6. Brown, R. P., Delp, M. D., Lindstedt, S. L., Rhomberg, L. R., and Beliles, R. P. 1997. Physiological parameter values for physiologically based pharmacokinetic models. Toxicol. Ind. Health 13: 407-484.
7. Dänicke, S., Swiech, E., Buraczewska, L., and Ueberschär, K. H. 2005. Kinetics and metabolism of zearalenone in young female pigs. J. Anim. Physiol. Anim. Nutr. 89: 268-276.
8. Dänicke, S., Ueberschär, K. H., Halle, I., Valenta, H., and Flachowsky, G. 2001. Excretion kinetics and metabolism of zearalenone in broilers in dependence on a detoxifying agent. Arch. Anim. Nutr. 55: 299-313.
9. Davies, B., and Morris, T. 1993. Physiological parameters in laboratory animals and humans. Pharm. Res. 10: 1093-1095.
10. Döll, S., Dänicke, S., and Schnurrbusch, U. 2003. The effect of increasing concentrations of Fusarium toxins in the diets for piglets on histological parameters of the uterus. Mycotoxin Res. 19: 73-76.
11. Everett, D. J., Perry, C. J., Scott, K. A., Martin, B. W., and Terry, M. K. 1987. Estrogenic potencies of resorcylic acid lactones and 17 beta-estradiol in female rats. J. Toxicol. Environ. Health 20: 435-443.
12. Food and Agriculture Organization. 2004. Worldwide regulations for mycotoxin in food and feed in 2003. FAO Food and Nutrition paper no. 81. Rome: Food and Agriculture Organization of the United Nations.
13. Hosseini-Yeganeh, M., and McLachlan, A. J. 2002 Physiologically based pharmacokinetic model for terbinafine in rats and humans. Antimicrob. Agents Chemother. 46: 2219-2228.
14. Jodlbauer, J., Zöllner, P., and Lindner, W. 2000. Determination of zeranol, taleranol, zearalenone, a-and b-zearalenol in urine and tissue by highperformance liquid chromatography-tandem mass spectrometry. Chromatographia 51: 681-687.
15. Joint FAO/WHO Expert Committee on Food Additives. 2000. Zearalenone. Safety evaluation of certain food additives and contaminants. WHO/FAO Food Additives Series 44. Geneva: International Programme on Chemical Safety, WHO.
16. Kleinova, M., Zöllinger, P., Kahlbacher, H., Hochsteiner, W., and Lindner, W. 2002. Metabolic profiles of the mycotoxin zearalenone and of the growth promoter zeranol in urine, liver, and muscle of heifers. J. Agric. Food Chem. 50: 4769-4776.
17. Kuiper-Goodman, T., Scott, P. M., and Watanabe, H. 1987. Risk assessment of the mycotoxin zearalenone. Regul. Toxicol. Pharmacol. 7: 253-306.
18. Mallis, L. M., Sarkahian, A. B., Harris, H. A., Zhang, M. Y., and McConnell, O. J. 2003. Determination of rat oral bioavailability of soy-derived phytoestrogens using an automated on-column extraction procedure and electrospray tandem mass spectrometry. J. Chromatogr. B 796: 71-86.
19. Mirocha, C. J., Pathre, S. V., and Robison, T. S. 1981. Comparative metabolism of zearalenone and transmission into bovine milk. Food Cosmet. Toxicol. 19: 25-30.
20. Prelusky, D. B., Warner, R. M., and Trenholm, H. L. 1989. Sensitive analysis of the mycotoxin zearalenone and its metabolites in biological fluids by high-performance liquid chromatography. J. Chromatogr. 494: 267-277.
21. Shin, B. S., Kim, C. H., Jun, Y. S., Kim, D. H., Lee, B. M., Yoon, C. H., Park, E. H., Lee, K. C., Han, S. Y., Park, K. L., Kim, H. S., and Yoo, S. D. 2004. Physiologically based pharmacokinetics of bisphenol A. J. Toxicol. Environ. Health A 67: 1971-1985.
22. Shin, B. S., Hong, S. H., Kim, H. J., Yoon, H. S., Kim, D. J., Hwang, S. W., Lee, J. B., and Yoo, S. D. 2009a. Development of a sensitive LC assay with fluorescence detection for the determination of zearalenone in rat serum. Chromatographia 69: 295-1259
23. Shin, B. S., Hong, S. H., Hwang, S. W., Kim, H. J., Lee, J. B., Yoon, H. S., Kim, D. J., and Yoo, S. D. 2009b. Determination of zearalenone by liquid chromatography/tandem mass spectrometry and application to a pharmacokinetic study. Biomed. Chromatogr. 23: 1014-1021.
24. Shin, B. S., Hong, S. H., Bulitta, J. B., Hwang, S. W., Kim, H. J., Lee, J. B., Yoon, H. S., Kim, D. J., and Yoo, S. D. 2009. Dose-linearity of pharmacokinetics, oral absorption and tissue distribution of zearalenone in rats. J. Toxicol. Environ. Health, this issue.
25. Songsermsakul, P., Sontag, G., Cichna-Markl, M., Zentek, J., and Razzazi-Fazeli, E. 2006. Determination of zearalenone and its metabolites in urine, plasma and faeces of horses by HPLC-APCI-MS. J. Chromatogr. B 843: 252-261.
26. Zinedine, A., Soriano, J. M., Moltó, J. C., and Males, J. 2007. Review on the toxicity, occurrence, metabolism, detoxification, regulation and intake of zearalenone: an oestrogenic mycotoxin. Food Chem. Toxicol. 45: 1-18.
27. Zöllinger, P., Jodlbauer, J., Kleinova, M., Kahlbacher, H., Kuhn, T., Hochsteiner, W., and Linder, W. 2002. Concentration levels of zearalenone and its metabolites in urine, muscle tissue, and liver samples of pigs fed with mycotoxin-contaminated oats. J. Agric. Food Chem. 50: 2494-2501.